AIRS — AirSculpt Technologies, Inc. Stock Price, Chart & AI Report

Negative Oct 6, 2026 • 22:41 UTC GlobeNewswire Inc. • Pomerantz Llp

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AirSculpt Technologies, Inc. - AIRS

Pomerantz LLP is investigating potential securities fraud claims against AirSculpt Technologies following a significant stock price decline of 45.11% on August 10, 2026, after the company reported lower-than-expected quarterly revenue of $42.9 million, down from $44.0 million year-over-year.

AIRS securities fraud class action lawsuit stock price decline revenue decline investor investigation

Sentiment note

The company is under investigation for potential securities fraud and experienced a dramatic 45.11% stock price drop following disappointing quarterly revenue results that declined year-over-year, indicating serious concerns about financial performance and possible misrepresentation to investors.

Negative Oct 6, 2026 • 22:36 UTC GlobeNewswire Inc. • Pomerantz Llp

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Securitize Corp. – SECZ

Pomerantz LLP has launched investigations into potential securities fraud and unlawful business practices at Securitize Corp., Fluence Energy, Inc., and AirSculpt Technologies, Inc. The law firm is seeking investors who suffered losses to join class action lawsuits against these companies.

SECZ FLNC AIRS securities fraud class action lawsuit investor losses fiduciary duty corporate misconduct

Sentiment note

Company is under investigation by Pomerantz LLP for potential securities fraud claims on behalf of investors, indicating alleged misconduct or misstatements.

Negative Sep 1, 2026 • 20:59 UTC GlobeNewswire Inc. • Pomerantz Llp

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AirSculpt Technologies, Inc. - AIRS

Pomerantz LLP is investigating AirSculpt Technologies for potential securities fraud following the company's announcement of declining quarterly revenue ($42.9M vs $44.0M year-over-year) on August 10, 2026. The news triggered a significant stock price decline of 45.11%, falling from $5.01 to $2.75 per share.

AIRS securities fraud class action lawsuit revenue decline stock price drop investor investigation

Sentiment note

The company faces a securities fraud investigation by a major law firm, reported declining year-over-year revenue, and experienced a severe 45% stock price decline following earnings announcement, indicating serious concerns about financial performance and potential corporate misconduct.

Positive Nov 17, 2025 • 22:32 UTC GlobeNewswire Inc. • Yogi Jashnani

AirSculpt Technologies Appoints Mike Doyle as Non-Executive Chairman of the Board

AirSculpt Technologies appointed Mike Doyle as Non-Executive Chairman of its Board of Directors. Doyle brings over 30 years of leadership experience in multi-center healthcare and has previously led Surgery Partners and founded MD Healthcare Partners.

AIRS SGRY healthcare body contouring board appointment leadership

Sentiment note

Company is expanding leadership with an experienced executive, signaling strategic growth and potential organizational development

Neutral Aug 1, 2025 • 10:00 UTC GlobeNewswire Inc. • Airsculpt Technologies, Inc.

AirSculpt Technologies Reports Second Quarter Fiscal 2025 Results

AirSculpt Technologies reported Q2 2025 financial results with declining case volume and revenue, but narrowed year-over-year revenue decline and reduced net loss. The company is piloting new offerings and remains confident in its growth strategy.

AIRS body contouring medical procedures financial results revenue decline GLP-1 treatments

Sentiment note

Mixed financial performance with revenue and case volume decline, but reduced net loss, strategic initiatives, and management's optimistic outlook suggest potential for future improvement

Positive Jun 16, 2025 • 10:45 UTC GlobeNewswire Inc. • N/A

AirSculpt Strengthens Balance Sheet with $10.0 Million Debt Paydown

AirSculpt Technologies, Inc. announced the voluntary prepayment of $10 million of its outstanding term loan debt using cash on hand, following the successful completion of its offering of 3,634,000 shares of common stock, which generated net proceeds of approximately $13.8 million.

AIRS AirSculpt common stock offering debt prepayment

Sentiment note

The company successfully completed a common stock offering, generating net proceeds of $13.8 million, and used a portion of the proceeds to prepay $10 million of its outstanding debt, which improves its capital structure and financial flexibility.

Neutral May 2, 2025 • 10:00 UTC GlobeNewswire Inc. • N/A

AirSculpt Technologies Reports First Quarter Fiscal 2025 Results and Full Year Guidance

AirSculpt Technologies, a provider of body contouring procedures, reported its Q1 2025 results. The company saw a decline in case volume and revenue compared to the prior year, leading to a net loss. However, the company expects sequential improvement in revenue as it focuses on increasing lead generation and consultations.

AIRS AirSculpt Technologies body contouring Q1 2025 earnings

Sentiment note

The company reported a decline in key metrics like case volume and revenue, leading to a net loss. However, the company expects to see sequential improvement in revenue going forward, indicating a neutral sentiment.

Negative Mar 14, 2025 • 10:00 UTC GlobeNewswire Inc. • N/A

AirSculpt Technologies Reports Fourth Quarter, and Full Year Fiscal 2024 Results

AirSculpt Technologies, a provider of body contouring procedures, reported a decline in revenue and case volume for the fourth quarter and full year 2024. The company is focused on stabilizing same-center sales performance and implementing cost reduction measures.

AIRS AirSculpt Technologies body contouring revenue decline cost reduction

Sentiment note

The article reports a decline in revenue and case volume for AirSculpt Technologies, indicating a challenging year for the company. However, the company is taking measures to stabilize its performance and improve profitability.

Neutral Nov 8, 2024 • 11:00 UTC GlobeNewswire Inc. • N/A

AirSculpt Technologies Reports Third Quarter Fiscal 2024 Results

AirSculpt Technologies, a provider of body contouring procedures, reported a decline in revenue and Adjusted EBITDA for Q3 2024 compared to the prior year. The company is focused on improving conversion of leads to cases and cost reduction efforts to return to positive revenue growth and improve margins.

AIRS AirSculpt Technologies body contouring revenue Adjusted EBITDA

Sentiment note

The company reported a decline in revenue and Adjusted EBITDA, but is taking steps to improve performance, indicating a neutral sentiment.

Unknown May 31, 2024 • 13:36 UTC Zacks Investment Research • Zacks Equity Research

Do Options Traders Know Something About AirSculpt (AIRS) Stock We Don't?

Investors need to pay close attention to AirSculpt (AIRS) stock based on the movements in the options market lately.

AIRS

Unknown May 24, 2024 • 13:55 UTC Zacks Investment Research • Zacks Equity Research

Here's Why AirSculpt Technologies (AIRS) Could be Great Choice for a Bottom Fisher

AirSculpt Technologies (AIRS) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

AIRS

Unknown May 24, 2024 • 13:35 UTC Zacks Investment Research • Zacks Equity Research

Down -38.41% in 4 Weeks, Here's Why AirSculpt Technologies (AIRS) Looks Ripe for a Turnaround

AirSculpt Technologies (AIRS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

AIRS